Alnylam Pharmaceuticals
ALNY
#534
Rank
HK$351.64 B
Marketcap
HK$2,662
Share price
0.81%
Change (1 day)
24.37%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company